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The elimination of malaria in Africa is sensibly focused
on the challenge of P. falciparum. However the parasite
species P. ovale curtisi, P. ovale wallikeri and P. malariae
occur across the continent at population prevalences ran-
ging from negligible, up to ~9% for P. ovale sp. and up to
~15% for P. malariae. All three species are able to recur
in the successfully treated patient months or years after
exposure, even if successful clearance of blood-stage
infections has occurred through antimalarial therapy. We
present some recent data from surveys in several African
localities as well as analyses of Malaria Reference Labora-
tory data for patterns of presentation of these parasite
species among imported malaria cases in the UK, and
consider the possibility that a substantial hidden burden
of infection exists. The public health implications
and challenges posed by these malaria species to malaria
eradication programmes will also be considered.
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